Assembly Biosciences, Inc.
ASMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40,177 | -$61,228 | -$93,092 | -$129,855 |
| Dep. & Amort. | $129 | $450 | $498 | $466 |
| Deferred Tax | $0 | $0 | $0 | -$2,531 |
| Stock-Based Comp. | $3,120 | $5,119 | $6,593 | $5,237 |
| Change in WC | -$11,948 | $76,341 | -$2,122 | -$11,401 |
| Other Non-Cash | -$2,241 | $2,061 | $3,660 | $44,688 |
| Operating Cash Flow | -$51,117 | $22,743 | -$84,463 | -$93,396 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$28 | -$255 | -$102 | -$3,096 |
| Net Acquisitions | $0 | $0 | $1,500 | $1,500 |
| Inv. Purchases | -$90,501 | -$133,922 | -$27,583 | -$160,446 |
| Inv. Sales/Matur. | $130,700 | $65,015 | $116,825 | $187,700 |
| Other Inv. Act. | $0 | $24 | $0 | $857 |
| Investing Cash Flow | $40,171 | -$69,138 | $90,640 | $26,515 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $29,294 | $13,689 | $325 | $52,806 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $155 | $129 | $289 | $258 |
| Financing Cash Flow | $29,449 | $13,818 | $614 | $53,064 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $18,503 | -$32,577 | $6,791 | -$13,817 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,841 | $52,418 | $45,627 | $59,444 |
| End Cash | $38,344 | $19,841 | $52,418 | $45,627 |
| Free Cash Flow | -$51,145 | $22,488 | -$84,565 | -$96,492 |